Altamont Pharma Acquisition Corp
Status: Stalled
U=S+W
W=S@11.50
| IPO Proceeds, $M | $100.00M |
|---|---|
| IPO Date | * |
| CEO | Mark Pearson |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Europe |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | TBD |
ALTP
ALTPU
ALTP/W
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.